| Literature DB >> 26055522 |
Núria Torner1,2,3, Núria Soldevila4, Juan Jose Garcia5, Cristian Launes5, Pere Godoy6,7, Jesús Castilla7,8, Angela Domínguez7,4.
Abstract
BACKGROUND: Hygiene behavior plays a relevant role in infectious disease transmission. The aim of this study was to evaluate non-pharmaceutical interventions (NPI) in preventing pediatric influenza infections.Entities:
Mesh:
Year: 2015 PMID: 26055522 PMCID: PMC4459072 DOI: 10.1186/s12889-015-1890-3
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Distribution of sociodemographic variables and underlying medical conditions for confirmed outpatient cases and controls
| Cases | Controls | P value | Cases | Controls | Crude OR | P value | ||
|---|---|---|---|---|---|---|---|---|
| (n = 239) | (n = 239) | (n = 239) | (n = 239) | (95 % CI) | ||||
|
| 5.4 ± 4.5 | 5.3 ± 4.6 | 0.48 |
| 23 (9.6 %) | 8 (3.3 %) | 3.23 (1.38 – 7.58) | 0.007 |
|
|
| 27 (11.3 %) | 13 (5.4 %) | 2.45 (1.17 – 5.14) | 0.02 | |||
| 0-4 | 134 (56.1 %) | 135 (56.5 %) | 0.29 |
| 4 (1.7 %) | 2 (0.8 %) | 2.00 (0.37 – 10.92) | 0.42 |
| 5-17 | 205 (44.0 %) | 104 (43.5 %) |
| 1 (0.4 %) | 2 (0.8 %) | 0.50 (0.04 – 5.51) | 0.57 | |
|
| 101 (42.3 %) | 108 (45.2 %) | 0.49 |
| 8 (3.3 %) | 3 (1.3 %) | 2.67 (0.71 – 10.05) | 0.15 |
|
|
| 4 (1.7 %) | 1 (0.4 %) | 4.00 (0.45 – 35.79) | 0.21 | |||
| White | 209 (88.9 %) | 218 (92.8 %) | 0.56 |
| 2 (1.1 %) | 3 (1.6 %) | 0.01 (0 – 1239.59) | 0.44 |
| Romany | 9 (3.8 %) | 5 (2.1 %) |
| 31 (13.0 %) | 41 (17.2 %) | 0.67 (0.38 – 1.18) | 0.16 | |
| Amerindian | 7 (3.0 %) | 6 (2.6 %) |
| 10 (4.2 %) | 4 (1.7 %) | 3.20 (0.86 – 11.91) | 0.08 | |
| Arab or North African | 6 (2.6 %) | 3 (1.3 %) |
| 21 (8.8 %) | 13 (5.4 %) | 1.73 (0.82 – 3.63) | 0.15 | |
| Other | 4 (1.7 %) | 3 (1.3 %) |
| 47 (19.7 %) | 32 (13.4 %) | 1.67 (0.99 – 2.82) | 0.05 | |
|
|
| 7 (2.9 %) | 3 (1.3 %) | 2.52 (0.65 – 9.81) | 0.18 | |||
| Secondary or higher | 168 (74.3 %) | 160 (70.5 %) | 0.35 | |||||
|
| 87 (36.6 %) | 98 (41.4 %) | 0.36 | |||||
Distribution of health information and non-pharmaceutical measures for confirmed outpatient cases and negative controls
| Cases | Controls | Crude OR | P value | Adjusted ORa | P value | |
|---|---|---|---|---|---|---|
| (n = 239) | (n = 239) | (95 % CI) | (95 % CI) | |||
|
| ||||||
| No | 56 (23.6 %) | 51 (22.0 %) | 1 | 1 | ||
| Yes | 181 (76.4 %) | 181 (78.0 %) | 0.83 (0.48 – 1.44) | 0.51 | 0.72 (0.40 – 1.31) | 0.29 |
|
| ||||||
| 1-4 times | 123 (52.3 %) | 107 (45.7 %) | 1 | 1 | ||
| >5 times | 112 (47.7 %) | 127 (54.3 %) | 0.69 (0.45 – 1.04) | 0.07 | 0.62 (0.39 – 0.99) | 0.04 |
|
| ||||||
| Never | 158 (67.2 %) | 170 (72.3 %) | 1 | 1 | ||
| Sometimes | 77 (32.8 %) | 65 (27.7 %) | 1.36 (0.85 – 2.17) | 0.21 | 1.54 (0.8 – 2.66) | 0.13 |
|
| ||||||
| Never | 50 (21.4 %) | 43 (18.3 %) | 1 | 1 | ||
| Sometimes | 184 (78.6 %) | 192 (81.7 %) | 0.73 (0.41 – 1.32) | 0.30 | 0.62 (0.29 – 1.31) | 0.21 |
|
| 2 (0.9 %) | 5 (2.2 %) | 0.44 (0.08 – 2.26) | 0.32 | 0.27 (0.02 – 1.28) | 0.09 |
|
| 79 (35.9 %) | 69 (31.7 %) | 1.52 (0.85 – 2.70) | 0.15 | 1.47 (0.79 – 2.75) | 0.22 |
aAdjusted for pneumonia in previous 2 years, asthma and disabling neurological disease
Distribution of medical conditions for confirmed outpatient cases and negative controls according to age group
| 0-4 years | 5-17 years | |||||||
|---|---|---|---|---|---|---|---|---|
| Cases | Controls | Crude OR | P value | Cases | Controls | Crude OR | P value | |
| (n = 122) | (n = 122) | (95 % CI) | (n = 93) | (n = 93) | (95 % CI) | |||
|
| 12 (9.8 %) | 2 (1.6 %) | 6.00 (1.34 – 26.81) | 0.02 | 8 (8.6 %) | 6 (6.5 %) | 1.48 (0.47 – 4.70) | 0.50 |
|
| 10 (8.2 %) | 4 (3.3 %) | 3.00 (0.81 – 11.08) | 0.10 | 16 (17.2 %) | 9 (9.7 %) | 2.07 (0.83 – 5.15) | 0.12 |
|
| 1 (0.8 %) | 0 (0.0 %) | - | - | 3 (3.2 %) | 2 (2.2 %) | 1.50 (0.25 – 8.98) | 0.66 |
|
| 0 (0.0 %) | 0 (0.0 %) | - | - | 1 (1.1 %) | 2 (2.2 %) | 0.50 (0.04 – 5.51) | 0.57 |
|
| 1 (0.8 %) | 3 (2.4 %) | 0.33 (0.03 – 3.20) | 0.34 | 6 (6.5 %) | 0 (0.0 %) | 65.29(0.09– 46313) | 0.21 |
|
| 0 (0.0 %) | 0 (0.0 %) | - | - | 4 (4.3 %) | 0 (0.0 %) | 65.29 (0.02 – 202501.6) | 0.31 |
|
| 0 (0.0 %) | 1 (1.1 %) | - | - | 2 (2.6 %) | 2 (2.6 %) | 0.01 (0 – 500061.3) | 0.58 |
|
| 18 (14.8 %) | 27 (22.0 %) | 0.50 (0.22 – 1.11) | 0.09 | 9 (9.7 %) | 11 (11.8 %) | 0.83 (0.33 – 2.11) | 0.69 |
|
| 4 (3.3 %) | 1 (0.8 %) | 4.00 (0.45 – 35.79) | 0.21 | 5 (5.4 %) | 2 (2.2 %) | 4.70 (0.52 – 42.78) | 0.17 |
|
| 13 (10.7 %) | 7 (5.7 %) | 2.20 (0.76 – 6.33) | 0.14 | 7 (7.5 %) | 5 (5.4 %) | 1.40 (0.44 – 4.41) | 0.57 |
|
| 16 (13.1 %) | 12 (9.8 %) | 1.50 (0.61 – 3.67) | 0.37 | 29 (31.2 %) | 18 (19.4 %) | 1.97 (0.97 – 3.96) | 0.06 |
|
| 1 (0.8 %) | 2 (1.6 %) | 0.50 (0.04 – 5.51) | 0.57 | 6 (6.5 %) | 1 (1.1 %) | 6.77 (0.81 – 56.84) | 0.08 |
Distribution of health information and non-pharmaceutical measures for confirmed outpatient cases and negative controls according to age group
| 0-4 years | 5-17 years | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cases | Controls | Crude OR | Adjusted ORa | P value | Cases | Controls | Crude OR | Adjusted ORb | P value | |
| (n = 122) | (n = 122) | (95 % CI) | (95 % CI) | (n = 93) | (n = 93) | (95 % CI) | (95 % CI) | |||
|
| ||||||||||
| No | 37 (30.6 %) | 32 (26.0 %) | 1 | 1 | 15 (16.3 %) | 14 (15.9 %) | 1 | 1 | ||
| Yes | 84 (69.4 %) | 91 (74.0 %) | 0.71 (0.34-1.48) | 0.74 (0.33 1.63) | 0.45 | 77 (83.7 %) | 74 (84.1 %) | 0.83 (0.33 – 2.11) | 0.72 (0.21 –2.50) | 0.61 |
|
| ||||||||||
| 1-4 times | 57 (48.3 %) | 54 (45.0 %) | 1 | 1 | 58 (62.4 %) | 42 (46.2 %) | 1 | 1 | ||
| >5 times | 61 (51.7 %) | 66 (55.0 %) | 0.80 (0.44- 1.47) | 0.91 (0.46-1.78) | 0.77 | 35 (37.6 %) | 49 (53.8 %) | 0.45 (0.23 – 0.87) | 0.47 (0.22 – 0.99) | 0.04 |
|
| ||||||||||
| Never | 84 (71.2 %) | 96 (79.3 %) | 1 | 1 | 62 (66.7 %) | 62 (68.1 %) | 1 | 1 | ||
| Sometimes | 34 (28.8 %) | 25 (20.7 %) | 1.59 (0.85 -2.98) | 1.45 (0.72 2.91) | 0.29 | 31 (33.3 %) | 29 (31.9 %) | 1.09 (0.48 – 2.47) | 1.29 (0.49 – 3.37) | 0.60 |
|
| ||||||||||
| Never | 22 (18.8 %) | 26 (21.5 %) | 1 | 1 | 26 (28.0 %) | 16 (17.6 %) | 1 | 1 | ||
| Sometimes | 95 (81.2 %) | 95 (78.5 %) | 1.36 (0.63-2.97) | 1.06 (0.44-2.56) | 0.90 | 67 (72.0 %) | 75 (82.4 %) | 0.27 (0.09 – 0.83) | 0.19 (0.04 – 0.86) | 0.03 |
a Adjusted for: pneumonia in previous 2 years and previous antibiotics. b Adjusted for: frequency of daily hand washing and hand washing after touching contaminated surface